Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Lymphoma, Large-Cell, Anaplastic

fingolimod hydrochloride has been researched along with Lymphoma, Large-Cell, Anaplastic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badihian, S; Manouchehri, N; Mirmosayyeb, O; Shaygannejad, V1
Bieber, T; Froehlich, A; Landsberg, J; Schmidt, S; Wenzel, J1
Connolly, A; Grandi, V; Palmer, R; Stefanato, CM; Weir, A; Whittaker, S1
Gräfe, R; Hildebrandt, U; Papathemeli, D; Ulrich, J; Zettl, UK1

Other Studies

4 other study(ies) available for fingolimod hydrochloride and Lymphoma, Large-Cell, Anaplastic

ArticleYear
Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod.
    Multiple sclerosis and related disorders, 2018, Volume: 19

    Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphoma, Large-Cell, Anaplastic; Multiple Sclerosis

2018
Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2018, Volume: 24, Issue:13

    Topics: Adult; Fingolimod Hydrochloride; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Multiple Sclerosis; T-Lymphocytes

2018
Primary cutaneous CD30
    The British journal of dermatology, 2018, Volume: 179, Issue:6

    Topics: Biopsy; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Receptors, Lysosphingolipid; Skin; Skin Neoplasms; T-Lymphocytes

2018
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:14

    Topics: Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Middle Aged; Multiple Sclerosis; Skin Neoplasms

2016